Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 24119631)

1.

Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia.

Schneider C, Corrigall R, Hayes D, Kyriakopoulos M, Frangou S.

Eur Psychiatry. 2014 Jan;29(1):1-10. doi: 10.1016/j.eurpsy.2013.08.001. Epub 2013 Oct 9. Review.

PMID:
24119631
2.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
3.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
4.

Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.

Kim Y, Kim BN, Cho SC, Kim JW, Shin MS.

Hum Psychopharmacol. 2008 Dec;23(8):715-22. doi: 10.1002/hup.982.

PMID:
18814190
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.

Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM.

Neuropsychopharmacology. 2003 May;28(5):995-1003. Epub 2003 Mar 26.

7.

Clozapine versus typical neuroleptic medication for schizophrenia.

Essali A, Al-Haj Haasan N, Li C, Rathbone J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000059. doi: 10.1002/14651858.CD000059.pub2. Review.

PMID:
19160174
8.

Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review.

Midbari Y, Ebert T, Kosov I, Kotler M, Weizman A, Ram A.

J Child Adolesc Psychopharmacol. 2013 Oct;23(8):516-21. doi: 10.1089/cap.2013.0050. Epub 2013 Oct 10.

PMID:
24111981
9.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B.

Am J Psychiatry. 2001 Apr;158(4):518-26.

PMID:
11282684
10.

Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.

Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL.

Arch Gen Psychiatry. 2006 Jul;63(7):721-30.

PMID:
16818861
11.

Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.

Muscatello MR, Bruno A, De Fazio P, Segura-Garcia C, Pandolfo G, Zoccali R.

Expert Opin Pharmacother. 2014 Nov;15(16):2329-45. doi: 10.1517/14656566.2014.956082. Epub 2014 Oct 5. Review.

PMID:
25284216
12.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
13.

Clozapine use in children and adolescents.

Gogtay N, Rapoport J.

Expert Opin Pharmacother. 2008 Feb;9(3):459-65. doi: 10.1517/14656566.9.3.459 . Review.

PMID:
18220495
14.

Risperidone augmentation of clozapine: a critical review.

Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, Paplos KG, Pappa DA, Christodoulou GN.

Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):350-5. Epub 2006 Aug 8. Review.

PMID:
16900439
15.

Management of schizophrenia in children and adolescents. The role of clozapine.

Remschmidt H, Fleischhaker C, Hennighausen K, Schulz E.

Paediatr Drugs. 2000 Jul-Aug;2(4):253-62. Review.

PMID:
10946414
16.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;10:CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
17.

Predictors of clinical outcome in schizophrenic patients responding to clozapine.

Mauri MC, Volonteri LS, Dell'Osso B, Regispani F, Papa P, Baldi M, Bareggi SR.

J Clin Psychopharmacol. 2003 Dec;23(6):660-4.

PMID:
14624196
18.

Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.

Bitter R, Demler TL, Opler L.

J Psychiatr Pract. 2008 Sep;14(5):265-70. doi: 10.1097/01.pra.0000336753.11943.7c.

PMID:
18832957
19.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
20.

Clozapine versus typical neuroleptic medication for schizophrenia.

Wahlbeck K, Cheine M, Essali MA.

Cochrane Database Syst Rev. 2000;(2):CD000059. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD000059.

PMID:
10796289
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk